Revenue
2023
2024
2025
Beta Bionics, Inc. (BBNX)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $100.3M | $65.1M | $12.0M |
| Gross profit | $55.5M | $35.9M | $6.3M |
| Research & development | $34.8M | $26.2M | $17.9M |
| Operating expenses | $127.2M | $81.1M | $42.2M |
| Operating income | −$71.7M | −$45.3M | −$35.9M |
| Net income | −$73.2M | −$54.8M | −$44.1M |
| Basic EPSper diluted share | -$1.81 | -$8.60 | -$8.31 |
| Diluted EPSper diluted share | -$1.81 | -$8.60 | -$8.31 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026Form 4 · 10b5-1 | Feider StephenChief Financial Officer | SellCommon Stock | 4.9K | $17.03 | $83.4K | 165.9K |
| Jun 26, 2026Form 4 · 10b5-1 | Feider StephenChief Financial Officer | SellCommon Stock | 5.1K | $17.05 | $87.0K | 165.9K |
| Jun 24, 2026Form 4 · 10b5-1 | Hopman MarkChief Commercial Officer | SellCommon Stock | 1.3K | $15.01 | $18.9K | 129.4K |
| Jun 24, 2026Form 4 · 10b5-1 | Jones ChristyDirector | SellCommon Stock | 1.4K | $15.00 | $21.1K | 26.0K |
| Jun 4, 2026Form 4 · 10b5-1 | Hopman MarkChief Commercial Officer | SellCommon Stock | 275 | $12.31 | $3.4K | 130.6K |